FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech announced on September 12, 2025 that the Indian Patent Office has granted a patent for its in-house developed process to manufacture plant-based Vitamin D3. The company is one of the world's leading producers of Vitamin D3 and serves over 400 customers across 60 countries. The patented process enables fully vegan and vegetarian-friendly Vitamin D3, targeting growing demand in nutraceutical and food fortification sectors. Management stated this strengthens the company's IP portfolio and positions it at the forefront of the plant-based nutrition trend. No financial figures or revenue projections were disclosed in the release.
Positive for shareholders as it strengthens Fermenta's competitive position in the growing plant-based nutrition market and adds to its IP moat, though the announcement is qualitative with no near-term revenue impact disclosed.